Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures.
Reguiai Z, Becherel PA, Fougerousse AC, Chaby G, Perrot JL, Begon E, Jacobzone-Lévêque C, Boulard C, Badaoui A, Poreaux C, David L, Quiles-Tsimaratos N, Lons-Danic D, Fite C, Liegeon AL, Patchinsky A, Parier J, Garcia C, Estève E, Mohty R, Mery-Bossard L, Maccari F. Reguiai Z, et al. Among authors: mery bossard l. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1307-e1309. doi: 10.1111/jdv.19302. Epub 2023 Jul 14. J Eur Acad Dermatol Venereol. 2023. PMID: 37415328 No abstract available.
New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases.
Méry-Bossard L, Bagny K, Chaby G, Khemis A, Maccari F, Marotte H, Perrot JL, Reguiai Z, Sigal ML, Avenel-Audran M, Boyé T, Grasland A, Gillard J, Jullien D, Toussirot E. Méry-Bossard L, et al. J Eur Acad Dermatol Venereol. 2017 Jan;31(1):181-186. doi: 10.1111/jdv.13759. Epub 2016 Jun 13. J Eur Acad Dermatol Venereol. 2017. PMID: 27291924
Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting.
Fougerousse AC, Maccari F, Beauchet A, Parier J, Boulard C, Becherel PA, Quiles-Tsimaratos N, Le Guyadec T, Thomas-Beaulieu D, Halioua B, Begon E, Bastien M, Perrot JL, Pallure V, Bilan P, Steff M, Pfister P, Vermersch-Langlin A, Boyé T, Mery-Bossard L, Maillard H, Kemula M, Girard C, Poiraud C, Monfort JB, Kupfer-Bessaguet I, Perrussel M, Lons-Danic D, Sultan N, Lorier E, Zeitoun M, Wagner L, Gabison G, Mahé E; GEM Resopso. Fougerousse AC, et al. J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e476-e478. doi: 10.1111/jdv.15804. Epub 2019 Jul 30. J Eur Acad Dermatol Venereol. 2019. PMID: 31310364 No abstract available.
Tattoo complications in treated and non-treated psoriatic patients.
Grodner C, Beauchet A, Fougerousse AC, Quiles-Tsimaratos N, Perrot JL, Barthelemy H, Parier J, Maccari F, Beneton N, Bouilly-Auvray D, Ruer-Mulard M, Boulard C, Jacobzone C, Thomas-Beaulieu D, Pourchot D, Méry-Bossard L, Chaby G, Girard C, Duval-Modeste AB, Vermersch-Langlin A, Delaunay J, Marc S, Kemula M, Steff M, Bilan P, Liégeon AL, Aubert H, Solyga B, Kluger N, Mahé E; GEM Resopso. Grodner C, et al. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):888-896. doi: 10.1111/jdv.15975. Epub 2019 Oct 24. J Eur Acad Dermatol Venereol. 2020. PMID: 31568596
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.
Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso. Fougerousse AC, et al. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9. J Eur Acad Dermatol Venereol. 2020. PMID: 32564417 Free PMC article. No abstract available.
Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis.
Phan C, Sigal ML, Estève E, Reguiai Z, Barthélémy H, Beneton N, Maccari F, Lahfa M, Thomas-Beaulieu D, Le Guyadec T, Vermersch-Langlin A, Mery-Bossard L, Pallure V, Kemula M, Labeille B, Beauchet A, Mahé E; GEM RESOPSO. Phan C, et al. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):78-82. doi: 10.1111/jdv.12850. Epub 2014 Nov 11. J Eur Acad Dermatol Venereol. 2016. PMID: 25389080
Development of monoclonal gammopathy under biotherapy in psoriasis: a French multicenter retrospective study.
Liegeon AL, Mahe E, Begon E, Poreaux C, Barbaud A, Esteve E, Quiles-Tsimaratos N, Avenel-Audran M, Schoeffler A, Mery-Bossard L, Pauwels C, Girard C, Maillard H, Barthelme D, Bernier C, Chaby G, Reguiai Z, Nguyen-Thi PL, Maccari F, Schmutz JL. Liegeon AL, et al. Eur J Dermatol. 2016 Jan-Feb;26(1):75-81. doi: 10.1684/ejd.2015.2700. Eur J Dermatol. 2016. PMID: 26878712
Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis.
Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse AC, Cinotti E, Romanelli M, Mery-Bossard L, Thomas-Beaulieu D, Parier J, Maccari F, Chaby G, Bastien M, Begon E, Samimi M, Prignano F, Beauchet A, Mahé E; GEM Resopso. Phan C, et al. Among authors: mery bossard l. Drugs Aging. 2020 Sep;37(9):657-663. doi: 10.1007/s40266-020-00781-y. Drugs Aging. 2020. PMID: 32696432
19 results